Showing results (3581-3590 of 9,339) with videos related to
Sort By:
Pageof 934
Cancer Medicine|June 3, 2024
Preliminary outcomes of boron neutron capture therapy for head and neck cancers as a treatment covered by public health insurance system in Japan: Real-world experiences over a 2-year periodSatoshi Takeno, Yuki Yoshino, Teruhito Aihara, et al.Cancer Medicine|June 3, 2024
Comparison of SOX and CAPOX in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: A randomized controlled trialXin Liu, Yongjia Yan, Li Lu, et al.Cancer Medicine|June 3, 2024
Targeting the core program of metastasis with a novel drug combinationGulimirerouzi Fnu, Georg F WeberCancer Medicine|June 18, 2024
Revisiting beta-2 microglobulin as a prognostic marker in diffuse large B-cell lymphomaJelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, et al.Cancer Medicine|June 14, 2024
Integrative network analysis of transcriptomics data reveals potential prognostic biomarkers for colorectal cancerMohita Mahajan, Angshuman Sarkar, Sukanta MondalCancer Medicine|May 31, 2024
Effect of body mass index and cholesterol-rich apolipoprotein-B-containing lipoproteins on clinical outcome in NSCLC patients treated with immune checkpoint inhibitors-based therapy: A retrospective analysisZixin Hu, Yumin Zheng, Jiabin Zheng, et al.Cancer Medicine|May 31, 2024
Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter studyChao An, Ran Wei, Wang Yao, et al.Cancer Medicine|June 20, 2024
Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of immune checkpoint inhibitorsLishi Lin, Aletta P I Houwink, Jolanda M van Dieren, et al.Cancer Medicine|May 29, 2024
Efficacy of first-line dual oral pyrotinib plus capetabine therapy in HER2-positive metastatic breast cancer: A real-world retrospective studyShuang Dai, Yong Zhang, Xiang Tan, et al.Cancer Medicine|July 6, 2024
Effect of Medicaid expansion on cancer treatment and survival among Medicaid beneficiaries and the uninsuredKristin M Primm, Hui Zhao, Naomi N Adjei, et al.Pageof 934